Key Financial Data Of Group

K Pharma,Inc. - Filing #7269885

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2019-11-01 to
2020-12-31
As at
2020-12-31
Key financial data of group
Business results of group
Net sales
JPY
1,000,000,000 JPY
JPY
JPY
JPY
Ordinary profit (loss)
-836,243,000 JPY
344,184,000 JPY
-359,233,000 JPY
-220,892,000 JPY
-269,562,000 JPY
Net assets
2,258,312,000 JPY
3,104,768,000 JPY
1,336,263,000 JPY
178,891,000 JPY
8,009,000 JPY
Total assets
2,353,073,000 JPY
3,313,902,000 JPY
1,374,566,000 JPY
205,767,000 JPY
56,983,000 JPY
Net assets per share
194.60
267.55
-122.77
-107.03
-84,539.31
Basic earnings (loss) per share
-72.94
25.42
-42.06
-30.09
-38,751.13
Diluted earnings per share
23.07
Equity-to-asset ratio
0.960 xbrli:pure
0.937 xbrli:pure
0.972 xbrli:pure
0.869 xbrli:pure
0.141 xbrli:pure
Rate of return on equity
xbrli:pure
0.117 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
28.3 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-983,719,000 JPY
454,425,000 JPY
-363,482,000 JPY
-196,320,000 JPY
JPY
Net cash provided by (used in) investing activities
-14,490,000 JPY
-11,099,000 JPY
-32,737,000 JPY
-250,000 JPY
JPY
Net cash provided by (used in) financing activities
JPY
1,486,235,000 JPY
1,544,285,000 JPY
368,201,000 JPY
JPY
Cash and cash equivalents
2,268,198,000 JPY
3,266,408,000 JPY
1,336,847,000 JPY
188,782,000 JPY
JPY
Number of employees
17 xbrli:pure
15 xbrli:pure
13 xbrli:pure
11 xbrli:pure
10 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.